PRL and prolactin-producing pituitary gland adenoma: Due to the possibility of mixed secretion of GH and PRL, insulin-like growth factor-1 (IGF-1) assessment is recommended for patients with PRLomas at diagnosis, while its long-term monitoring is not recommended (113).